Planet 13 Holdings (PLNH) Change in Receivables (2022 - 2026)
Planet 13 Holdings' (PLNH) quarterly Change in Receivables came in at -$2.5 million in Q1 2026, down 1666.45% year-on-year from $160964.0 in Q1 2025, and down 2162.68% on a QoQ basis from $122240.0 in Q3 2025.
Planet 13 Holdings (PLNH) Change in Receivables (2022 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 5 years of Change in Receivables data on file, last reported at -$2.5 million in Q1 2026.
- On a quarterly basis, Change in Receivables fell 1666.45% year-over-year to -$2.5 million in Q1 2026; TTM through Mar 2026 was -$2.3 million, a 480.32% decrease from a year earlier, with the FY2024 full-year figure at $277229.0, up 311.84% from the prior year.
- Change in Receivables for Q1 2026 stood at -$2.5 million, down from $122240.0 in the prior quarter.
- Over the last five years, Change in Receivables for PLNH reached as high as $217536.0 in Q3 2024 and fell as low as -$2.5 million in Q1 2026.
- Historically, Change in Receivables has averaged -$177838.2 across 5 years, with a median of -$1547.0 in 2022.
- Across the five-year window, Change in Receivables jumped 835.42% in 2024 and sank 1666.45% in 2026, its largest moves.
- Year by year, Change in Receivables stood at $21188.0 in 2022, then slumped by 214.6% to -$24282.0 in 2023, then soared by 835.42% to $178575.0 in 2024, then sank by 31.55% to $122240.0 in 2025, then slumped by 2162.68% to -$2.5 million in 2026.
- Per Business Quant data, the three most recent Change in Receivables figures were -$2.5 million in Q1 2026, $122240.0 in Q3 2025, and -$38619.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -78.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 106.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -621.82 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -38.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 126.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 81.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Planet 13 Holdings | 39.35 Mn | 23.09 Mn | 9.41 Mn | -2.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.52 Mn |
| Mar 31, 2026 | -2.52 Mn |
| Sep 30, 2025 | 122,240.00 |
| Sep 30, 2025 | 122,240.00 |
| Jun 30, 2025 | -38,619.00 |
| Jun 30, 2025 | -38,619.00 |
| Mar 31, 2025 | 160,964.00 |
| Mar 31, 2025 | 160,964.00 |
| Dec 31, 2024 | 178,575.00 |
| Dec 31, 2024 | 178,575.00 |
| Sep 30, 2024 | 217,536.00 |
| Sep 30, 2024 | 217,536.00 |
| Jun 30, 2024 | 41,580.00 |
| Jun 30, 2024 | 41,580.00 |
| Mar 31, 2024 | -160,462.00 |
| Mar 31, 2024 | -160,462.00 |
| Dec 31, 2023 | -24,282.00 |
| Dec 31, 2023 | -24,282.00 |
| Sep 30, 2023 | -100,789.00 |
| Sep 30, 2023 | -100,789.00 |